Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025? [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
Company Research Source: Yahoo! Finance
the shares climbing 27% from January through a peak in November. The company, the global leader in cystic fibrosis (CF) treatments, has established a long track record of earnings growth thanks to this business -- and in recent times has made significant progress on broadening into other billion-dollar treatment areas. But in recent weeks, Vertex stock has declined, and last week it lost nearly 12% in one trading session after an element from a clinical trial report disappointed investors. Meanwhile, Vertex is heading for two pieces of news in January that could be enormous for the company. Should you take advantage of recent losses to buy Vertex on the dip before the new year? Or is the recent clinical trial news a warning for investors? Let's find out. Image source: Getty Images. Vertex's cystic fibrosis empire First, let's consider the Vertex story so far. The company has built a CF empire, offering several treatments known as CFTR modulators. These products work by corre Show less Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CRSP alerts
Opt-in for
CRSP alerts

from News Quantified
Opt-in for
CRSP alerts

from News Quantified